Literature DB >> 26081155

The Severity of Cecal Ligature and Puncture-Induced Sepsis Correlates with the Degree of Encephalopathy, but the Sepsis Does Not Lead to Acute Activation of Spleen Lymphocytes in Mice.

I C Jeremias1, V J Victorino2, J L Machado2, W A Barroso2, S K Ariga2, T M Lima2, F G Soriano2.   

Abstract

Septic encephalopathy represents the most frequently observed form of encephalopathy in intensive care units. Interactions between the immune and nervous systems have been observed in experimental sepsis. Therefore, the aim of the current study was to characterize the effect of different severities of sepsis on encephalopathy and the inflammatory profile of the spleen. We hypothesized that different grades of sepsis severity would lead to variations in encephalopathy and activation of spleen cells. We induced sepsis of different severities in Balb/c mice by cecal ligature and puncture (CLP). Six and 12 h after CLP induction, behavioral impairment was assessed by the SmithKline/Harwell/Imperial College/Royal Hospital/Phenotype Assessment (SHIRPA) test. The animals were then killed, and the plasma, spleen, and hippocampus were removed. Levels of the encephalopathy marker S100β were measured in plasma. Spleens were weighed and then a characterization of splenic lymphocytes was performed by flow cytometry (cytotoxic T lymphocyte, T helper lymphocytes, B lymphocytes, T regulatory cells, and Th17 cells). Cytokine levels in the spleen and hippocampus were determined by enzyme-linked immunosorbent assay (ELISA), and cytokine levels in plasma were performed with MilliPlex® technology. Our results showed that behavioral impairment as measured by the SHIRPA test and elevation in plasma S100β levels were significant in moderate and severe CLP groups compared to those in the sham control group. Regarding immunological alterations, we were unable to observe changes in the weights of the spleen and the profile of lymphocytes 6 h after CLP. However, several cytokines, including IL-6, IL-10, and IL-1β, were increased in spleen and plasma. In conclusion, we observed variations in encephalopathy as measured by plasma S100β, which were mediated by the severity of sepsis; however, we did not observe a different activation of spleen cells 6 h post-CLP, despite evidence of inflammation. Taken together, our data indicate that the severity of sepsis impacts the brain in absence of a change in the spleen lymphocyte profile.

Entities:  

Keywords:  Inflammation; Lymphocytes; SHIRPA; Sepsis; Septic encephalopathy

Mesh:

Substances:

Year:  2015        PMID: 26081155     DOI: 10.1007/s12035-015-9290-3

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  57 in total

1.  Drug intervention trials in sepsis.

Authors:  Cristiane Ritter; Michael Andrades; Adalisa Reinke; José Cláudio F Moreira; Felipe Dal-Pizzol
Journal:  Lancet       Date:  2004 Aug 7-13       Impact factor: 79.321

2.  Remarks ON THE FUNCTIONS OF AN OUT-PATIENT DEPARTMENT: Made at the Opening of the New Out - patient Department, Cardiff Infirmary, May 20th, 1908.

Authors:  W Osler
Journal:  Br Med J       Date:  1908-06-20

3.  Endotoxin tolerance: selective alterations in gene expression and protection against lymphocyte death.

Authors:  Edielle S Melo; Tatiana Goloubkova; Denise F Barbeiro; Renata Gorjão; Dewton Vasconcelos; Csaba Szabo; Rui Curi; Thais Martins de Lima Salgado; Irineu T Velasco; Francisco G Soriano
Journal:  Immunobiology       Date:  2009-10-02       Impact factor: 3.144

Review 4.  Treating patients with severe sepsis.

Authors:  A P Wheeler; G R Bernard
Journal:  N Engl J Med       Date:  1999-01-21       Impact factor: 91.245

5.  Serum S-100B concentration provides additional information fot the indication of computed tomography in patients after minor head injury: a prospective multicenter study.

Authors:  Peter Biberthaler; Ulrich Linsenmeier; Klaus-Juergen Pfeifer; Michael Kroetz; Thomas Mussack; Karl-Georg Kanz; Eduard F J Hoecherl; Felix Jonas; Ingo Marzi; Phillip Leucht; Marianne Jochum; Wolf Mutschler
Journal:  Shock       Date:  2006-05       Impact factor: 3.454

6.  Traumatic brain damage in minor head injury: relation of serum S-100 protein measurements to magnetic resonance imaging and neurobehavioral outcome.

Authors:  T Ingebrigtsen; K Waterloo; E A Jacobsen; B Langbakk; B Romner
Journal:  Neurosurgery       Date:  1999-09       Impact factor: 4.654

7.  Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease.

Authors:  E R Peskind; W S Griffin; K T Akama; M A Raskind; L J Van Eldik
Journal:  Neurochem Int       Date:  2001 Nov-Dec       Impact factor: 3.921

Review 8.  Sepsis and cytokines: current status.

Authors:  T S Blackwell; J W Christman
Journal:  Br J Anaesth       Date:  1996-07       Impact factor: 9.166

9.  Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.

Authors:  W S Griffin; L C Stanley; C Ling; L White; V MacLeod; L J Perrot; C L White; C Araoz
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

Review 10.  Biomarkers in septic encephalopathy: a systematic review of clinical studies.

Authors:  Paula Veriato Zenaide; Dimitri Gusmao-Flores
Journal:  Rev Bras Ter Intensiva       Date:  2013-03
View more
  2 in total

1.  Protective effects of recombinant human brain natriuretic peptide on the myocardial injury induced by acute carbon monoxide poisoning.

Authors:  Na Li; Xun Gao; Weizhan Wang; Pu Wang; Baoyue Zhu
Journal:  Cardiovasc Diagn Ther       Date:  2020-12

2.  The Neuroprotective Effect of Short Chain Fatty Acids Against Sepsis-Associated Encephalopathy in Mice.

Authors:  Jiaming Liu; Yangjie Jin; Yanglie Ye; Yahui Tang; Shanshan Dai; Mengfang Li; Guangju Zhao; Guangliang Hong; Zhong-Qiu Lu
Journal:  Front Immunol       Date:  2021-01-28       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.